Effects of lactose as an inducer on expression of Helicobacter pylori rUreB and rHpaA, and Escherichia coli rLTKA63 and rLTB

World Journal of Gastroenterology

Volumn 10, Issue 12, 2004, Pages 1755-1758

  Yan, Jie ^a   Zhao, Shou Feng ^a   Mao, Ya Fei ^a   Luo, Yi Hui ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; ESCHERICHIA COLI ENTEROTOXIN; HELICOBACTER PYLORI VACCINE; ISOPROPYL THIOGALACTOSIDE; LACTOSE; RECOMBINANT PROTEIN; UREASE;

ARTICLE; CHRONIC GASTRITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ESCHERICHIA COLI; GASTROINTESTINAL INFECTION; GENETIC ENGINEERING; GENETIC PARAMETERS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMAGE ANALYSIS; IMAGING SYSTEM; IMMUNOGENICITY; NONHUMAN; PEPTIC ULCER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN TARGETING; RECOMBINANT GENE; TEMPERATURE MEASUREMENT; TIME;

EID: 3142764047     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i12.1755     Document Type: Article

References (28)

1. Niu WX, Qin XY, Liu H, Wang CP. Clinicopathological analysis of patients with gastric. World J Gastroenterol 2001; 7: 281-284
2. Peng ZS, Liang ZC, Liu MC, Ouyang NT. Studies on gastric epithelial cell proliferation and apoptosis in Hp associated gastric ulcer. Shijie Huaren Xiaohua Zazhi 1999; 7: 218-219
3. Kate V, Ananthakrishnan N, Badrinath S. Effect of Helicobacter pylori eradication on the ulcer recurrence rate after simple closure of perforated duodenal ulcer: retrospective and prospective randomized controlled studies. Br J Surg 2001; 88: 1054-1058
4. Yao YL, Zhang WD. Relation between Helicobacter pylori and gastric cancer. Shijie Huaren Xiaohua Zazhi 2001; 9: 1045-1049
5. Lu SY, Pan XZ, Peng XW, Shi ZL. Effect of Hp infection on gastric epithelial cell kinetics in stomach diseases. Shijie Huaren Xiaohua Zazhi 1999; 7: 760-762
6. Liu HF, Liu WW, Fang DC. Study of the relationship between apoptosis and proliferation in gastric carcinoma and its pre-cancerous lesion. Shijie Huaren Xiaohua Zazhi 1999; 7: 649-651
7. Zhu ZH, Xia ZS, He SG. The effects of ATRA and 5-Fu on telomerase activity and cell growth of gastric cancer cells in vitro. Shijie Huaren Xiaohua Zazhi 2000; 8: 669-673
8. Cai L, Yu SZ. A molecular epidemiologic study on gastric cancer in Changle, Fujian Province. Shijie Huaren Xiaohua Zazhi 1999; 7: 652-655
9. Suganuma M, Kurusu M, Okabe S, Sueoka N, Yoshida M, Wakatsuki Y, Fujiki H. Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. Cancer Res 2001; 61: 6356-6359
10. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 8298-8332
11. Hiyama T, Haruma K, Kitadai Y, Miyamoto M, Tanaka S, Yoshihara M, Sumii K, Shimamoto F, Kajiyama G. B-cell monoclonality in Helicobacter pylori-associated chronic atrophic gastritis. Virchows Arch 2001; 483: 232-237
12. Nakamura S, Matsumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M, Yao T, Tsuneyoshi M, Iida M, Fujishima M. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 2001; 48: 454-460
13. Morgner A, Miehlke S, Fischbach W, Schmitt W, Muller-Hermelink H, Greiner A, Thiede C, Schetelig J, Neubauer A, Stolte M, Ehninger G, Bayerdorffer E. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 2001; 19: 2041-2048
14. Houben MH, van de Beek D, Hensen EF, Craen AJ, Rauws EA, Tytgat GN. A systematic review of Helicobacter pylori eradication therapy- the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999; 13: 1047-1055
15. Donovan RS, Robinson CW, Glick BR. Review: optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter. J Ind Microbiol 1996; 16: 145-154
16. Yildirim N, Mackey MC. Feedback regulation in the lactose operon: a mathematical modeling study and comparison with experimental data. Biophys J 2003; 84: 2841-2851
17. Menzella HG, Ceccarelli EA, Gramajo HC. Novel Escherichia coli strain allows efficient recombinant protein production using lactose as inducer. Biotechnol Bioeng 2003; 82: 809-817
18. Mao YF, Yan J, LI LW. Cloning, expression and identification of hpaA gene from a clinical isolate of Helicobacter pylori. Zhejiang Daxue Xuebao 2003; 32: 9-12
19. Chen Z, Yan J, Mao YF. Construction of prokaryotic expression system of ureB gene from a clinical isolate of Helicobacter pylori and identification of immunogenicity of the fusion protein. Zhejiang Daxue Xuebao 2003; 32: 4-8
20. Xia XP, Yan J, Zhao SF. Cloning, expression and identification of Escherichia coli LTB gene and Vibrio cholerae CTB gene. Zhejiang Daxue Xuebao 2003; 32: 17-20
21. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. Cold Spring Harbor Laboratory Press 1989: pp 18.47-18.61
22. Recavarren Ascencios R, Recavarren Arce S. Chronic atrophic gastritis: pathogenic mechanisms due to cellular hypersensitivity. Rev Gastroenterol Peru 2002; 22: 199-205
23. Crabtree JE. Eradication of chronic Helicobacter pylori infaction by therapeutic vaccination. Gut 1998; 43: 7-8
24. Yuki Y, Kiyono H. New generation of mucosal adjuvants for the induction of protective immunity. Rev Med Virol 2003; 13: 293-310
25. Corthesy-Theulaz I, Porta N, Glauser M, Saraga E, Vaney AC, Haas R, Kraehenbuhl JP, Blum AL, Michetti P. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobactor pylori infection in mice. Gastroenterology 1995; 109: 115-121
26. Opazo P, Muller I, Rollan A, Valenzuela P, Yudelevich A, Garcia-de la Guarda R, Urra S, Venegas A. Serological response to Helicobacter pylori recombiant antigens in Chilean infected patients with duodenal ulcer, non-ulcer dyspepsia and gastric cancer. Apmis 1999; 107: 1069-1078
27. Verweij WR, de Haan L, Holtrop M, Agsteribbe E, Brands R, van Scharrenburg GJ, Wilschut J. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen. Vaccine 1998; 16: 2069-2076
28. Baudner BC, Giuliani MM, Verhoef JC, Rappuoli R, Junginger HE, Giudice GD. The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines. Vaccine 2003; 21: 3837-3844